HIGHLIGHTS
- who: from the (UNIVERSITY) have published the Article: Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies, in the Journal: (JOURNAL)
- what: There is a need for standardized jLS disease assessments and treatment regimens to be able to compare treatment efficacy.
SUMMARY
2-5 June 2011 Purpose LS can cause significant morbidity in the growing child, including joint contractures and facial and extremity hemiatrophy. Optimal therapy is not known, and few randomized clinical trials have been carried out. A prior survey of Childhood Arthritis and Rheumatology Research Alliance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.